Position in A
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$134,789,241
+$87,713,793 QoQ
Shares Held
1,014,750
+145.7% QoQ
Ownership
0.359%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#48
of 1,112 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,374,793,482 across 32 Diagnostics & Research names. A ranks #15 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
5,116,336 | $2,565,126,216 | |
| 2 | NTRA |
Natera, Inc.
|
9,021,895 | $2,448,993,397 | |
| 3 | DHR |
Danaher Corp /De/
|
11,450,715 | $2,181,132,192 | |
| 4 | DGX |
Quest Diagnostics Inc
|
5,444,986 | $1,154,064,781 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
2,069,677 | $1,096,080,242 | |
| 6 | GH |
Guardant Health, Inc.
|
6,514,952 | $977,438,248 | |
| 7 | WAT |
Waters Corp /De/
|
2,177,958 | $816,821,367 | |
| 8 | RVTY |
Revvity, Inc.
|
5,530,850 | $615,362,370 |
All Filings in A
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $134,789,241 | 1,014,750 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $47,075,448 | 413,015 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $58,984,439 | 433,486 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $57,168,757 | 445,413 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $56,786,411 | 481,200 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $61,697,123 | 527,416 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $147,823,436 | 1,100,368 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $389,686,056 | 2,624,502 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $376,653,705 | 2,905,606 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,242,954,277 | 8,542,054 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,042,603,765 | 7,499,128 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $825,881,831 | 7,385,815 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $968,490,492 | 8,053,975 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,137,006,222 | 8,218,926 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,153,360,330 | 7,707,052 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $767,579,010 | 6,314,924 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,977,848,780 | 16,652,764 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,174,113,750 | 16,429,485 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,462,665,613 | 21,689,105 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,601,392,888 | 22,861,632 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,489,149,204 | 23,605,637 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,960,532,582 | 23,285,611 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,786,034,397 | 23,512,823 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,391,202,585 | 23,689,346 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,119,648,652 | 23,986,066 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,703,502,326 | 23,785,288 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||